Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
Pakyz
Amy L
AL
Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University Medical College of Virginia Campus, Richmond, Virginia 23298-0533, USA. apakyz@vcu.edu
Carroll
Norman V
NV
Harpe
Spencer E
SE
Oinonen
Michael
M
Polk
Ronald E
RE
D000046:Academic Medical Centers / Q000706:statistics & numerical data*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology; D014640:Vancomycin / Q000627:therapeutic use*; D055815:Young Adult
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D014640:Vancomycin